Pretreatment Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab

PURPOSE: This study aimed to assess the prognostic significance of the neutrophil-lymphocyte ratio (NLR) in patients with unresectable hepatocellular carcinoma (u-HCC) treated with hepatic artery infusion chemotherapy (HAIC) combined with lenvatinib and camrelizumab. PATIENTS AND METHODS: We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yongqiang, Zhu, Guoqing, Xie, Jin, Luo, Laihui, Deng, Wei, Lin, Liucong, Tao, Jiahao, Hu, Zhigao, Shan, Renfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642375/
https://www.ncbi.nlm.nih.gov/pubmed/37965074
http://dx.doi.org/10.2147/JHC.S432134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642375/
https://www.ncbi.nlm.nih.gov/pubmed/37965074
http://dx.doi.org/10.2147/JHC.S432134

Ejemplares similares